Treatment Recommendation for Acute Bacterial Sinusitis in Children with Penicillin Allergy
For children with penicillin allergy and acute bacterial sinusitis, treat with cefdinir, cefuroxime, or cefpodoxime as first-line therapy for at least 10 days. 1
Recommended Antibiotic Options
The 2014 American Academy of Pediatrics guideline explicitly addresses penicillin-allergic children and provides clear alternatives:
- Cefdinir (Omnicef)
- Cefuroxime (Ceftin)
- Cefpodoxime
These second- and third-generation cephalosporins are appropriate for both type 1 and non-type 1 penicillin hypersensitivity reactions 1. Recent evidence demonstrates that the risk of serious allergic reactions to these cephalosporins in penicillin-allergic patients is negligible and no greater than in non-allergic patients 2.
Critical Pitfall: Avoid These Antibiotics
Do NOT use trimethoprim/sulfamethoxazole or azithromycin in penicillin-allergic children with sinusitis. 1 Surveillance studies demonstrate significant resistance of Streptococcus pneumoniae and Haemophilus influenzae to these agents, making them ineffective choices despite their non-penicillin structure.
Treatment Duration
Treat for at least 10 days, or alternatively continue antibiotics for 7 days after the child becomes symptom-free 1. This individualized approach ensures adequate treatment while avoiding unnecessary prolonged therapy in asymptomatic children.
Alternative for Severe Cases or Inability to Take Oral Medications
If the child is vomiting, cannot tolerate oral medications, or is unlikely to adhere to initial doses:
- Ceftriaxone 50 mg/kg IM or IV once 1
- After clinical improvement, transition to oral cephalosporin therapy
When to Reassess Treatment
Reassess within 72 hours if:
- Symptoms worsen (progression of initial symptoms or new symptoms appear)
- No improvement occurs (persistent symptoms without reduction) 2
At this point, either initiate antibiotics if observing, or change antibiotics if already treating.
Important Context on Cross-Reactivity
The historical concern about cephalosporin use in penicillin-allergic patients has been largely debunked. The guideline specifically notes that second- and third-generation cephalosporins carry almost no risk of cross-reactivity with penicillin allergies 2. This makes them safe and appropriate first-line choices for this population.
Microbiology Considerations
The primary pathogens in pediatric acute bacterial sinusitis are S. pneumoniae (30-66%), H. influenzae (20-30%), and Moraxella catarrhalis (12-28%) 3. The recommended cephalosporins provide adequate coverage against these organisms, including many resistant strains.